Anuncio
Anuncio

BBIO

BBIO logo

BridgeBio Pharma, Inc. Common Stock

84.05
USD
Patrocinado
+0.35
+0.42%
12 ago, 13:17 UTC -4
Apertura

Panorámica financiera de BridgeBio Pharma, Inc. Common Stock

Cap. de Mercado
16.48B
Beta
0.96
Beneficios Por Acción (BPA)
-3.57
Ratio Precio/Valor (P/V) Contable
--
Margen de explotación
-97.03%
Ratio de Endeudamiento total (D/C)
-98.83%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
--
Ratio de liquidez
1.23%
Flujo de caja libre
-268.89M
Perfil de BBIO

Gráfico de Beneficios

Beneficios de BBIO

Últimas noticias y pronósticos

Ver todo

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$927.47
+6.79%
Nvidia Corp logo
Nvidia Corp$223.86
+2.92%
Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$144.47
+8.39%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,366.40
+7.50%
Nebius Group N.V. Class A Ordinary Shares logo
Nebius Group N.V. Class A Ordinary Shares$245.67
+27.14%
Intel Corp logo
Intel Corp$101.97
+4.36%
Lumentum Holdings Inc. Common Stock logo
Lumentum Holdings Inc. Common Stock$940.42
+14.60%
Anuncio